Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 73.9 M77.4 M77.9 M86.9 M 316.1 M Research & development ———— — Operating income 101.1 M97.8 M103 M119.1 M 421 M Non-Operating Income, Total -1.2 M-1 M-700 K1 M -1.9 M Interest expense, net of interest capitalized 12.2 M-13.4 M-13 M-35.6 M -49.8 M Non-Operating Income, excl. Interest Expenses -12.2 M13.4 M13 M35.6 M 49.8 M Unusual income/expense -1.2 M-1 M-700 K1 M -1.9 M Pretax income 87.7 M83.4 M89.3 M108.9 M 369.3 M Equity in earnings ———— — Taxes 19.2 M23.4 M21.9 M17.2 M 81.7 M Non-controlling/minority interest ———— — After tax other income/expense -1.7 M-1.8 M-1.8 M-1.9 M -7.2 M Net income before discontinued operations 68.5 M60 M67.4 M91.7 M 287.6 M Discontinued operations ———— — Net income 68.5 M60 M67.4 M91.7 M 287.6 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 68.5 M60 M67.4 M91.7 M 287.6 M Basic earnings per share (Basic EPS) 2.181.92.142.92 9.14 Diluted earnings per share (Diluted EPS) 2.171.92.132.89 9.09 Average basic shares outstanding 31.37 M31.49 M31.52 M31.48 M — Diluted shares outstanding 31.55 M31.62 M31.64 M31.63 M — EBITDA 46.5 M41.1 M46.5 M113.8 M 247.9 M EBIT 27.8 M19.7 M24.6 M32.2 M 104.3 M Cost of revenue 240.8 M254.7 M257.2 M288 M 1.04 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 18.7 M21.4 M21.9 M81.6 M 143.6 M